stoxline Quote Chart Rank Option Currency Glossary
  
BioLife Solutions, Inc. (BLFS)
21.72  0.63 (2.99%)    05-24 16:00
Open: 21.36
High: 21.92
Volume: 226,234
  
Pre. Close: 21.09
Low: 20.87
Market Cap: 1,000(M)
Technical analysis
2024-05-24 4:51:32 PM
Short term     
Mid term     
Targets 6-month :  26.98 1-year :  31.51
Resists First :  23.1 Second :  26.98
Pivot price 20.69
Supports First :  18.53 Second :  15.72
MAs MA(5) :  21.63 MA(20) :  19.97
MA(100) :  17.87 MA(250) :  16.54
MACD MACD :  1.1 Signal :  1
%K %D K(14,3) :  74.1 D(3) :  75.3
RSI RSI(14): 63.8
52-week High :  24.5 Low :  8.92
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ BLFS ] has closed below upper band by 35.0%. Bollinger Bands are 143% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 21.94 - 22.09 22.09 - 22.21
Low: 20.59 - 20.75 20.75 - 20.87
Close: 21.51 - 21.76 21.76 - 21.96
Company Description

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.

Headline News

Thu, 23 May 2024
Amalgamated Bank Sells 945 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) - Defense World

Sun, 19 May 2024
CSafe and BioLife Solutions, Inc. announce partnership to expand supply chain solutions for the cell and gene therapy ... - The Globe and Mail

Tue, 14 May 2024
Revenues Not Telling The Story For BioLife Solutions, Inc. (NASDAQ:BLFS) After Shares Rise 25% - Simply Wall St

Mon, 13 May 2024
Broker Revenue Forecasts For BioLife Solutions, Inc. (NASDAQ:BLFS) Are Surging Higher - Simply Wall St

Sun, 12 May 2024
Analysts Are Upgrading BioLife Solutions, Inc. (NASDAQ:BLFS) After Its Latest Results - Yahoo Finance

Sat, 11 May 2024
Should You Investigate BioLife Solutions, Inc. (NASDAQ:BLFS) At US$19.54? - Simply Wall St

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 45 (M)
Shares Float 33 (M)
Held by Insiders 3.5 (%)
Held by Institutions 102.8 (%)
Shares Short 3,100 (K)
Shares Short P.Month 3,030 (K)
Stock Financials
EPS -1.52
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 7.48
Profit Margin -46.4 %
Operating Margin -41.5 %
Return on Assets (ttm) -8.4 %
Return on Equity (ttm) -19 %
Qtrly Rev. Growth -26 %
Gross Profit (p.s.) 0
Sales Per Share 3.16
EBITDA (p.s.) -1
Qtrly Earnings Growth 0 %
Operating Cash Flow -13 (M)
Levered Free Cash Flow -5 (M)
Stock Valuations
PE Ratio -14.29
PEG Ratio -2
Price to Book value 2.9
Price to Sales 6.86
Price to Cash Flow -78.72
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android